65
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Overexpression of Snail induces epithelial–mesenchymal transition and a cancer stem cell–like phenotype in human colorectal cancer cells

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Epithelial–mesenchymal transition (EMT) is a critical process providing tumor cells with the ability to migrate and escape from the primary tumor and metastasize to distant sites. Recently, EMT was shown to be associated with the cancer stem cell (CSC) phenotype in breast cancer. Snail is a transcription factor that mediates EMT in a number of tumor types, including colorectal cancer (CRC). Our study was done to determine the role of Snail in mediating EMT and CSC function in CRC. Human CRC specimens were stained for Snail expression, and human CRC cell lines were transduced with a retroviral Snail construct or vector control. Cell proliferation and chemosensitivity to oxaliplatin of the infected cells were determined by the MTT (colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. Migration and invasion were determined in vitro using modified Boyden chamber assays. EMT and putative CSC markers were analyzed using Western blotting. Intravenous injection of tumor cells was done to evaluate their metastatic potential in mice. Snail was overexpressed in human CRC surgical specimens. This overexpression induced EMT and a CSC-like phenotype in human CRC cells and enhanced cell migration and invasion ( P < 0.002 vs. control). Snail overexpression also led to an increase in metastasis formation in vivo ( P < 0.002 vs. control). Furthermore, the Snail-overexpressing CRC cells were more chemoresistant to oxaliplatin than control cells. Increased Snail expression induces EMT and the CSC-like phenotype in CRC cells, which enhance cancer cell invasion and chemoresistance. Thus, Snail is a potential therapeutic target in metastatic CRC.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Epithelial-mesenchymal transitions in development and disease.

          The epithelial to mesenchymal transition (EMT) plays crucial roles in the formation of the body plan and in the differentiation of multiple tissues and organs. EMT also contributes to tissue repair, but it can adversely cause organ fibrosis and promote carcinoma progression through a variety of mechanisms. EMT endows cells with migratory and invasive properties, induces stem cell properties, prevents apoptosis and senescence, and contributes to immunosuppression. Thus, the mesenchymal state is associated with the capacity of cells to migrate to distant organs and maintain stemness, allowing their subsequent differentiation into multiple cell types during development and the initiation of metastasis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Identification of selective inhibitors of cancer stem cells by high-throughput screening.

            Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have not been possible due to the rarity of these cells within tumor cell populations and their relative instability in culture. We describe here an approach to screening for agents with epithelial CSC-specific toxicity. We implemented this method in a chemical screen and discovered compounds showing selective toxicity for breast CSCs. One compound, salinomycin, reduces the proportion of CSCs by >100-fold relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug. Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces increased epithelial differentiation of tumor cells. In addition, global gene expression analyses show that salinomycin treatment results in the loss of expression of breast CSC genes previously identified by analyses of breast tissues isolated directly from patients. This study demonstrates the ability to identify agents with specific toxicity for epithelial CSCs.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel.

              Metastasis, the cardinal feature of malignant tumors, is an important clinical variable in patient prognosis. To understand the basis for metastasis, we systematically selected for highly invasive cells from breast cancer cell lines, MCF7 and MDA-MB-453, with moderate to low invasive ability using Boyden chamber invasion assay. The four-cycle selected invasive lines, named MCF7-I4 and MDA-MB-453-I4, respectively, displayed epithelial-mesenchymal transition (EMT) and dramatically enhanced invasive ability. EMT changes were corroborated with decreased level of E-cadherin and increased vimentin, fibronectin, and beta(1) integrin. Twist, a basic helix-loop-helix transcription factor, and AKT2, a known proto-oncogene, were found to be elevated in the invasive cells compared with the parental. Ectopic expression and knockdown of Twist by short interference RNA resulted in significant increase and reduction, respectively, of AKT2 protein and mRNA expression. Twist bound to E-box elements on AKT2 promoter and enhanced its transcriptional activity. Moreover, silencing AKT2 decreased Twist-promoted migration, invasion, and paclitaxel resistance. Reintroducing AKT2 largely rescued the phenotype resulted from knockdown of Twist in I4 cells, suggesting that AKT2 is a downstream target and functional mediator of Twist. Finally, we observed a 68.8% correlation of elevated Twist and AKT2 expression in late-stage breast cancers as oppose to 13% in early-stage breast cancers. Our study identifies Twist as a positive transcriptional regulator of AKT2 expression, and Twist-AKT2 signaling is involved in promoting invasive ability and survival of breast cancer cells.
                Bookmark

                Author and article information

                Journal
                Cancer Med
                Cancer Med
                cam4
                Cancer Medicine
                Blackwell Publishing Ltd
                2045-7634
                2045-7634
                August 2012
                08 June 2012
                : 1
                : 1
                : 5-16
                Affiliations
                [1 ]Department of Cancer Biology, The University of Texas MD Anderson Cancer Center Houston, Texas
                [2 ]Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center Houston, Texas
                [3 ]Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center Houston, Texas
                [4 ]The University of Texas Graduate School of Biomedical Sciences Houston, Texas
                [5 ]Metastasis Research Center, The University of Texas MD Anderson Cancer Center Houston, Texas
                Author notes
                Lee M. Ellis, MD, Department of Cancer Biology and Surgical Oncology, Unit 173, The University of Texas MD Anderson Cancer Center, P.O. Box 301402, Houston, TX 77230-1402. Tel: +713-792-6926; Fax: +713-792-4689; E-mail: lellis@ 123456mdanderson.org

                Funding Information

                This work was supported, in part, by National Institutes of Health Cancer Center Support Grant CA016672, NIH grant T32CA009599 (E. S. and F. T.), The MD Anderson Research Trust (S. A. M.) The William C. Liedtke, Jr., Chair in Cancer Research (L. M. E.), The Jon Hall Cancer Research Fund (L. M. E), and an R. E. “Bob” Smith Fellowship (S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

                Article
                10.1002/cam4.4
                3544430
                23342249
                589fc398-ffc3-4f49-948f-b6e8884b0f21
                © 2012 The Authors. Published by Blackwell Publishing Ltd.

                Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

                History
                : 01 March 2012
                : 11 April 2012
                : 15 April 2012
                Categories
                Cancer Biology
                Original Research

                Oncology & Radiotherapy
                emt,snail,migration,colorectal cancer,cancer stem cells
                Oncology & Radiotherapy
                emt, snail, migration, colorectal cancer, cancer stem cells

                Comments

                Comment on this article